Thalassemias: Overview of Pathophysiology and Treatment

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

K. Fertrin

Pyruvate Kinase Deficiency: Clinical Manifestations and Treatment Ap…

Agios

K. Yotsumoto Fertrin

Impact and Risks of Chronic Anemia in Thalassemia Patients

Farrukh Shah

Case-Based Discussion: Managing Non-Transfusion-Dependent Thalassemia

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

A. Taher

Managing Benign Hematology Disorders

Indy Hematology Review

C. Kessler

Putting the Freeze on Cold Agglutinin Disease

i3 Health

C. Broome

PKD: Diagnosis, Treatment and Monitoring for Complications

Stanford Medicine

M. Chien

Mitapivat in PKD: Results of the ACTIVATE Trial and Updated Treatmen…

Stefan Eber

Advances in Hemolytic Anemias: Enzymopathies, Membrane Defects, Auto…

Scripps Health

I. Weitz

PKD Epidemiology, Diagnosis, and Management

Stefan Eber

Thalassemia: Overview of Pathophysiology and Risk for Malignancies

Ali Taher

CAD: The Basics and Development

Kelly Davidson

Diagnosis and Testing Considerations for Cold Agglutinin Disease

Julia Cunningham

TTP Case Discussion: Differential Diagnosis of TMA

BMFcases

T. Bat, S. Cataland

The Impact of Mitapivat Treatment on Work/School Activity for Adult …

Kevin Kuo

Overview of the Classification of Hemolytic Anemia

The Blood Project

W. Aird

Anemia and Thrombocytopenia Basics

UNC Lineberger Comprehensive Cancer Center

N. Vogler

The Role of Complement in Disease: Focus on PNH, aHUS, CAPS, and CAD

Ilene Weitz

Preventing Relapse in iTTP

Senthil Sukumar

Cold Agglutinin Disease: Pharmacologic Treatment and Clinical Monito…

Irina Murakhovskaya